An algorithm for the design of group sequential triangular tests for single-arm clinical trials with a binary endpoint

被引:1
|
作者
McWilliams, Thomas P. [1 ]
机构
[1] Drexel Univ, Dept Decis Sci, Philadelphia, PA 19104 USA
关键词
triangular test; sequential test; single arm trials; binary trials;
D O I
10.1002/sim.4060
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Consider the problem of testing H(0):p <= p(0) vs H(1):p>p(0), where p could, for example, represent the response rate to a new drug. The group sequential TT is an efficient alternative to a single-stage test as it can provide a substantial reduction in the expected number of test subjects. Whitehead provides formulas for determining stopping boundaries for this test. Existing research shows that test designs based on these formulas (WTTs) may not meet Type I error and/or power specifications, or may be over-powered at the expense of requiring more test subjects than are necessary. We present a search algorithm, with program available from the author, which provides an alternative approach to triangular test design. The primary advantage of the algorithm is that it generates test designs that consistently meet error specifications. In tests on nearly 1000 example combinations of n (group size), p(0), p(1), alpha, and beta the algorithm-determined triangular test (ATT) design met specified Type I error and power constraints in every case considered, whereas WTT designs met constraints in only 10 cases. Actual Type I error and power values for the ATTs tend to be close to specified values, leading to test designs with favorable average sample number performance. For cases where the WTT designs did meet Type I error and power constraints, the corresponding ATT designs also had the advantage of providing, on average, a modest reduction in average sample numbers calculated at p(0), p(1), and (p(0)+p(1))/2. Copyright (C) 2010 John Wiley & Sons, Ltd.
引用
收藏
页码:2794 / 2801
页数:8
相关论文
共 50 条
  • [1] Single-Arm Phase II Group Sequential Trial Design With Survival Endpoint at a Fixed Time Point
    Wu, Jianrong
    Xiong, Xiaoping
    [J]. STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2014, 6 (04): : 289 - 301
  • [2] Single-arm clinical trials: design, ethics, principles
    Wang, Minyan
    Ma, Huan
    Shi, Yun
    Ni, Haojie
    Qin, Chu
    Ji, Conghua
    [J]. BMJ SUPPORTIVE & PALLIATIVE CARE, 2024,
  • [3] Bayesian design and conduct of phase II single-arm clinical trials with binary outcomes: A tutorial
    Zohar, Sarah
    Teramukai, Satoshi
    Zhou, Yinghui
    [J]. CONTEMPORARY CLINICAL TRIALS, 2008, 29 (04) : 608 - 616
  • [4] Conditional Probability of Survival as a Proposed Endpoint for Future Single-Arm Clinical Trials in Glioblastoma
    Patel, Chirag B.
    Thomas, Reena P.
    Nagpal, Seema
    Recht, Lawrence D.
    [J]. ANNALS OF NEUROLOGY, 2017, 82 : S206 - S207
  • [5] Statistical Testing of Single and Multiple Endpoint Hypotheses in Group Sequential Clinical Trials
    Huque, Mohammad
    Mushti, Sirisha
    Alosh, Mohamed
    [J]. BIOPHARMACEUTICAL APPLIED STATISTICS SYMPOSIUM, VOL 3: PHARMACEUTICAL APPLICATIONS, 2018, : 119 - 149
  • [6] Bayesian Sequential Monitoring of Single-Arm Trials: A Comparison of Futility Rules Based on Binary Data
    Sambucini, Valeria
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (16)
  • [7] BAYESIAN SEQUENTIAL MONITORING DESIGNS FOR SINGLE-ARM CLINICAL-TRIALS WITH MULTIPLE OUTCOMES
    THALL, PF
    SIMON, RM
    ESTEY, EH
    [J]. STATISTICS IN MEDICINE, 1995, 14 (04) : 357 - 379
  • [8] Adaptive sequential design for phase II single-arm oncology trials: an expansion of Simon's design
    Gao, Ping
    Zhang, Weidong
    [J]. JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2024,
  • [9] Bayesian Design of Single-arm Phase II Clinical Trials with Continuous Monitoring
    Johnson, Valen E.
    Cook, John D.
    [J]. CLINICAL TRIALS, 2009, 6 (03) : 217 - 226
  • [10] Isotonic design for single-arm biomarker stratified trials
    Li, Lang
    Ivanova, Anastasia
    [J]. STATISTICAL METHODS IN MEDICAL RESEARCH, 2024, 33 (06) : 945 - 952